Lekarze w zakresie Chemioterapia przy białaczce w Izrael — Strona 2

Dr. Hila Magen is a leading Israeli hemato-oncologist at Sheba Medical Center. She heads the Multiple Myeloma and Amyloidosis Unit. Dr. Magen specializes in treating complex plasma cell disorders and high-risk myeloma. She is a principal investigator for innovative point-of-care CAR-T therapy programs. Her work brings advanced immunotherapies into routine clinical care.

• Authored over 100 scientific publications and landmark myeloma studies.
• Completed fellowships at MD Anderson and University of Arkansas for Medical Sciences.
• Performs CAR-T cell therapy and bone marrow transplantations.
• Works at Sheba Medical Center, ranked 7th worldwide in 2026 by Newsweek.

Ordynator Centrum Onkologii w Centrum Medycznym Assuta – lider w opiece onkologicznej, ze szczególnym uwzględnieniem leczenia białaczki.

• Onkolog specjalizujący się w protokołach chemioterapii
• Zajmuje się złożonymi przypadkami białaczki w centrum medycznym najwyższej klasy
• Kieruje programami leczenia Centrum Onkologii

Dr. Iris Kventsel is a pediatric hemato-oncologist and bone marrow transplant specialist at Sheba Medical Center. She treats childhood sarcomas like Ewing sarcoma and osteosarcoma at the Edmond and Lily Safra Children’s Hospital. Dr. Kventsel integrates targeted therapies with cellular treatments for complex childhood cancers. She serves on the academic staff at Tel Aviv University Faculty of Medicine.

• Specializes in bone marrow transplantation and CAR T-cell therapy for pediatric patients.
• Researches genetic cancer predisposition, including Li-Fraumeni syndrome and susceptibility genes.
• Published in major journals on stem cell biology and surgical oncology (HIPEC).
• Works at Sheba Medical Center, ranked among the world’s top 10 hospitals.

Dr. Elad Jacoby is a pioneer of pediatric CAR T–cell therapy in Israel. He heads the Pediatric Cell Therapy Center at Sheba Medical Center. Dr. Jacoby specializes in treating relapsed and high-risk pediatric leukemias and lymphomas. He completed fellowships at Johns Hopkins and the U.S. National Cancer Institute.

• Medical Director of the Advanced Biotherapy Center at Sheba Medical Center.
• Authored over 240 scientific publications in pediatric hemato-oncology.
• Board-certified in both Pediatrics and Pediatric Hematology and Oncology.
• Leads the integration of CAR T–cell therapy with bone marrow transplantation.

Wiodący izraelski specjalista w dziedzinie immunoterapii raka płuca – prof. Peled kieruje Oddziałem Onkologii Klatki Piersiowej w Centrum Onkologicznym Davidoff.

• Ekspert w dziedzinie medycyny spersonalizowanej i immuno-onkologii
• Laureat nagrody ASCO MERIT za badania nad rakiem płuca
• Przewodniczący Komitetu Wczesnego Wykrywania i Prewencji IASLC
• Ukończył szkolenie specjalizacyjne (fellowship) na Uniwersytecie Kolorado w Denver